Genexine Inc
KOSDAQ:095700
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genexine Inc
KOSDAQ:095700
|
KR |
|
Hedef Holding AS
IST:HEDEF.E
|
TR |
|
Intesa Sanpaolo SpA
F:IES
|
IT |
|
H
|
Huvitz Co Ltd
KOSDAQ:065510
|
KR |
|
MedCap AB (publ)
STO:MCAP
|
SE |
|
T
|
Thanachart Capital PCL
SET:TCAP
|
TH |
|
U
|
United Airlines Holdings Inc
BMV:UAL
|
US |
|
K
|
Kyungchang Industrial
KOSDAQ:024910
|
KR |
|
S
|
Sankyo Co Ltd
XMUN:SOK
|
JP |
Intrinsic Value
Is Genexine Inc undervalued or overvalued?
See the intrinsic value estimate for Genexine Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Genexine Inc looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Genexine Inc’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Genexine Does
Genexine Inc. is a South Korean biopharmaceutical company that discovers and develops protein-based medicines, with a focus on biologic drugs and antibody-like therapies. Its main work is early-stage research and clinical development rather than large-scale drug manufacturing, so it turns scientific targets into candidate medicines that can be tested in patients.
- Headquarters
- Korea KR
- IPO date
- Sep 15, 2009
Revenue & Expenses Breakdown
Genexine Inc
Earnings Waterfall
Genexine Inc
The intrinsic value for Genexine Inc (095700) under the Base Case is hidden KRW.
Compared with the current market price of 2 460 KRW, the stock appears hidden.